Cargando…
Amino acids – Guidelines on Parenteral Nutrition, Chapter 4
Protein catabolism should be reduced and protein synthesis promoted with parenteral nutrion (PN). Amino acid (AA) solutions should always be infused with PN. Standard AA solutions are generally used, whereas specially adapted AA solutions may be required in certain conditions such as severe disorder...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
German Medical Science GMS Publishing House
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795371/ https://www.ncbi.nlm.nih.gov/pubmed/20049071 http://dx.doi.org/10.3205/000083 |
_version_ | 1782175427041689600 |
---|---|
author | Stein, J. Boehles, H. J. Blumenstein, I. Goeters, C. Schulz, R. |
author_facet | Stein, J. Boehles, H. J. Blumenstein, I. Goeters, C. Schulz, R. |
author_sort | Stein, J. |
collection | PubMed |
description | Protein catabolism should be reduced and protein synthesis promoted with parenteral nutrion (PN). Amino acid (AA) solutions should always be infused with PN. Standard AA solutions are generally used, whereas specially adapted AA solutions may be required in certain conditions such as severe disorders of AA utilisation or in inborn errors of AA metabolism. An AA intake of 0.8 g/kg/day is generally recommended for adult patients with a normal metabolism, which may be increased to 1.2–1.5 g/kg/day, or to 2.0 or 2.5 g/kg/day in exceptional cases. Sufficient non-nitrogen energy sources should be added in order to assure adequate utilisation of AA. A nitrogen calorie ratio of 1:130 to 1:170 (g N/kcal) or 1:21 to 1:27 (g AA/kcal) is recommended under normal metabolic conditions. In critically ill patients glutamine should be administered parenterally if indicated in the form of peptides, for example 0.3–0.4 g glutamine dipeptide/kg body weight/day (=0.2–0.26 g glutamine/kg body weight/day). No recommendation can be made for glutamine supplementation in PN for patients with acute pancreatitis or after bone marrow transplantation (BMT), and in newborns. The application of arginine is currently not warranted as a supplement in PN in adults. N-acetyl AA are only of limited use as alternative AA sources. There is currently no indication for use of AA solutions with an increased content of glycine, branched-chain AAs (BCAA) and ornithine-α-ketoglutarate (OKG) in all patients receiving PN. AA solutions with an increased proportion of BCAA are recommended in the treatment of hepatic encephalopathy (III–IV). |
format | Text |
id | pubmed-2795371 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | German Medical Science GMS Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-27953712010-01-04 Amino acids – Guidelines on Parenteral Nutrition, Chapter 4 Stein, J. Boehles, H. J. Blumenstein, I. Goeters, C. Schulz, R. Ger Med Sci Article Protein catabolism should be reduced and protein synthesis promoted with parenteral nutrion (PN). Amino acid (AA) solutions should always be infused with PN. Standard AA solutions are generally used, whereas specially adapted AA solutions may be required in certain conditions such as severe disorders of AA utilisation or in inborn errors of AA metabolism. An AA intake of 0.8 g/kg/day is generally recommended for adult patients with a normal metabolism, which may be increased to 1.2–1.5 g/kg/day, or to 2.0 or 2.5 g/kg/day in exceptional cases. Sufficient non-nitrogen energy sources should be added in order to assure adequate utilisation of AA. A nitrogen calorie ratio of 1:130 to 1:170 (g N/kcal) or 1:21 to 1:27 (g AA/kcal) is recommended under normal metabolic conditions. In critically ill patients glutamine should be administered parenterally if indicated in the form of peptides, for example 0.3–0.4 g glutamine dipeptide/kg body weight/day (=0.2–0.26 g glutamine/kg body weight/day). No recommendation can be made for glutamine supplementation in PN for patients with acute pancreatitis or after bone marrow transplantation (BMT), and in newborns. The application of arginine is currently not warranted as a supplement in PN in adults. N-acetyl AA are only of limited use as alternative AA sources. There is currently no indication for use of AA solutions with an increased content of glycine, branched-chain AAs (BCAA) and ornithine-α-ketoglutarate (OKG) in all patients receiving PN. AA solutions with an increased proportion of BCAA are recommended in the treatment of hepatic encephalopathy (III–IV). German Medical Science GMS Publishing House 2009-11-18 /pmc/articles/PMC2795371/ /pubmed/20049071 http://dx.doi.org/10.3205/000083 Text en Copyright © 2009 Stein et al. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free to copy, distribute and transmit the work, provided the original author and source are credited. |
spellingShingle | Article Stein, J. Boehles, H. J. Blumenstein, I. Goeters, C. Schulz, R. Amino acids – Guidelines on Parenteral Nutrition, Chapter 4 |
title | Amino acids – Guidelines on Parenteral Nutrition, Chapter 4 |
title_full | Amino acids – Guidelines on Parenteral Nutrition, Chapter 4 |
title_fullStr | Amino acids – Guidelines on Parenteral Nutrition, Chapter 4 |
title_full_unstemmed | Amino acids – Guidelines on Parenteral Nutrition, Chapter 4 |
title_short | Amino acids – Guidelines on Parenteral Nutrition, Chapter 4 |
title_sort | amino acids – guidelines on parenteral nutrition, chapter 4 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795371/ https://www.ncbi.nlm.nih.gov/pubmed/20049071 http://dx.doi.org/10.3205/000083 |
work_keys_str_mv | AT steinj aminoacidsguidelinesonparenteralnutritionchapter4 AT boehleshj aminoacidsguidelinesonparenteralnutritionchapter4 AT blumensteini aminoacidsguidelinesonparenteralnutritionchapter4 AT goetersc aminoacidsguidelinesonparenteralnutritionchapter4 AT schulzr aminoacidsguidelinesonparenteralnutritionchapter4 AT aminoacidsguidelinesonparenteralnutritionchapter4 |